Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1999
08/03/1999US5932580 PDGF receptor kinase inhibitory compounds their preparation and compositions
08/03/1999US5932576 3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
08/03/1999US5932575 Cardiac diseases improving agents
08/03/1999US5932574 Anticancer agent
08/03/1999US5932572 Topical anti-glaucoma compositions
08/03/1999US5932569 Antiallergens
08/03/1999US5932568 6-methoxy-1H-benzotriazole-5-carboxamide derivatives and pharmaceutical compositions containing them
08/03/1999US5932565 Vitamin D analogues
08/03/1999US5932564 Methods for the prevention and treatment of gastrointestinal disorders
08/03/1999US5932563 Methods for treating spinal cord injury
08/03/1999US5932562 Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
08/03/1999US5932561 Dietary composition with lipid binding properties for weight management and serum lipid reduction
08/03/1999US5932560 Treatment of conditions and disease
08/03/1999US5932558 Adenosine receptor agonists for the promotion of wound healing
08/03/1999US5932555 Terpenoid compound 0406TP-1
08/03/1999US5932554 Prevent binding of toxins to receptors
08/03/1999US5932553 Illudin analogs useful as antitumor agents
08/03/1999US5932549 Treating alzheimer*s disease, septic shock, acute myelogenous leukemia, stroke, and inflammatory bowel disease
08/03/1999US5932542 Composition and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof
08/03/1999US5932541 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-l-histidyl-l-prolinam ide or a pharmaceutically acceptable salt thereof
08/03/1999US5932538 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
08/03/1999US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins
08/03/1999US5932437 Orally administering to wild rodents a mixture of grains, sugars, and antibiotics like tetracycline, doxycycline, erythromycin, azithromycin, minocycline, metronidazole, or salts; interruption of enzootic cycle
08/03/1999US5932423 Cyclic nucleotide phosphodiesterases
08/03/1999US5932252 Mixture of potassium compound and thiazide diuretic
08/03/1999US5932249 Budesonide pellets with a controlled released pattern and process for producing the same
08/03/1999US5932248 Ionic polymer matrix
08/03/1999US5932247 Microcrystalline cellulose, lactose and pregelatinized starch; gelatin; croscarmellose sodium
08/03/1999US5932246 Cardiovascular disorders
08/03/1999US5932243 Galenical formulations
08/03/1999US5932242 Anticarcinogenic agents, antiinflammatory agents
08/03/1999US5932241 Cationic lipid DNA complexes for gene targeting
08/03/1999US5932239 Transdermal therapeutic system with protection against hydrolysis
08/03/1999US5932238 Galanthamine containing transdermal applicator for the treatment of alcoholism
08/03/1999US5932236 Pharmaceutical composition and methods for using it
08/03/1999US5932234 Rinsable skincare composition
08/03/1999US5932229 Topical compounds
08/03/1999US5932228 Dermatological compositions and method of treatment of skin lesions therewith
08/03/1999US5932226 Method and kit for determining the optimum dosage level of physiologically useful substances
08/03/1999US5932215 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discrete erythema
08/03/1999CA2261086A1 Inhibition of mmp-2 activity by oral bacteria and siderophores
08/03/1999CA2184734C 3''-desmethoxy derivatives of erythromycin and azithromycin
08/03/1999CA2182101C Neuroprotective compounds
08/03/1999CA2171871C Stable solvates of avermectin compounds
08/03/1999CA2171561C K-252a derivatives which enhance neurotrophin-induced activity
08/03/1999CA2170278C Inhibition of smooth muscle cell migration by (r)-amlodipine
08/03/1999CA2005986C Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
08/03/1999CA2005815C Antiviral acyclic nucleoside derivatives
08/03/1999CA2003213C Antimycotically active cyclopropyl-substituted azolylmethylcarbinols
08/03/1999CA1340692C Method of potentiating an immune response and compositions therefor
08/03/1999CA1340690C Semi-synthetic rhodomycins, a process for their preparation and their use as cytostatics
07/1999
07/30/1999CA2260445A1 Methods and compositions for protecting animals and humans against attack and infestation by arthropod and helminth parasites
07/30/1999CA2260431A1 1,4-diaryl-3-fluoro-2-butene compounds for protecting animals and humans against attack and infestation by arthropod parasites
07/30/1999CA2246001A1 Novel compounds
07/29/1999WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor
07/29/1999WO1999037788A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
07/29/1999WO1999037781A1 Mutants of il-16, processes for their production, and their use
07/29/1999WO1999037760A1 Inhibition of cytokine production
07/29/1999WO1999037753A1 Enzyme catalyzed therapeutic agents
07/29/1999WO1999037658A1 Ustilipides, method for the production and the use thereof
07/29/1999WO1999037653A1 New cytotoxic tris(oxazole)-containing macrolides
07/29/1999WO1999037652A1 Tricyclic indolene substituted oxazolidinones
07/29/1999WO1999037651A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037649A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037648A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037647A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037646A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037645A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037644A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037641A1 Novel bicyclene-substituted oxazolidinones
07/29/1999WO1999037639A1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
07/29/1999WO1999037637A1 Benzamide derivatives as vasopressin antagonists
07/29/1999WO1999037635A1 Quinoline derivatives as antibacterials
07/29/1999WO1999037633A1 Isoflavane derivatives and immunopotentiating compositions containing the same
07/29/1999WO1999037632A1 Alternate method for acylating 10-deacetylbaccatin iii selectively at the c-10 position
07/29/1999WO1999037630A1 Oxazolidinone combinatorial libraries, compositions and methods of preparation
07/29/1999WO1999037625A1 2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
07/29/1999WO1999037623A2 Sulphonamide derivatives for treatment of cns disorders
07/29/1999WO1999037622A1 Nitrogenous heterocyclic derivatives and medicine thereof
07/29/1999WO1999037621A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
07/29/1999WO1999037619A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037618A1 Phenylalanine derivatives useful as pharmaceutical agents
07/29/1999WO1999037617A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037616A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
07/29/1999WO1999037614A1 Azetidinecarboxamide derivatives for the treatment of cns disorders
07/29/1999WO1999037613A1 Azetidinecarboxamide derivatives for treating cns disorders
07/29/1999WO1999037612A1 Azetidinecarboxamide derivatives for treating cns disorders
07/29/1999WO1999037609A1 Novel naphthyl-substituted and anilide-substituted sulfonamides
07/29/1999WO1999037608A1 Novel naphthyl substituted and heterocyclic substituted sulfonamides
07/29/1999WO1999037607A1 Potassium channel inhibitors
07/29/1999WO1999037606A1 New derivatives of sulfonic, phosphonic and phosphinic aminoalkane acids, their production and their use as medicaments
07/29/1999WO1999037605A1 Vla-4 antagonists
07/29/1999WO1999037604A2 Dialkyl ureas as calcitonin mimetics
07/29/1999WO1999037600A1 Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
07/29/1999WO1999037311A1 Cellulose derivatives and colorectal cancer risk reduction
07/29/1999WO1999037310A1 Methods of decreasing or preventing pain using spicamycin or derivatives thereof
07/29/1999WO1999037309A1 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation
07/29/1999WO1999037307A1 Pharmaceutically active compounds and methods of use thereof
07/29/1999WO1999037306A1 Pharmaceutically active compounds and methods of use thereof
07/29/1999WO1999037305A1 Pharmaceutically active morpholinol
1 ... 6466 6467 6468 6469 6470 6471 6472 6473 6474 6475 6476 6477 6478 6479 6480 6481 6482 6483 6484 6485 6486 ... 7860